![Tsuguo Sasaki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tsuguo Sasaki
Directeur/Membre du Conseil chez Japan BCG Laboratory KK
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Shin Kaitani | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Manabu Sugano | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Shiro Katayama | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Naoki Nakata | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Takahiko Ikegami | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Jun Saito | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Hoko Yamashita | M | - |
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Japon | 7 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Tsuguo Sasaki
- Réseau Personnel